Penserra Capital Management LLC Revolution Medicines, Inc. Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$24.35 - $33.7 $41,151 - $56,953	-1,690 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$23.95 - $33.41 $479 - $668	20 Added 1.2%	1,690 $46,000
Q2 2021 Aug 12, 2021	BUY	$29.0 - $47.44 $1,160 - $1,897	40 Added 2.45%	1,670 $53,000
Q1 2021 May 13, 2021	BUY	$37.21 - $54.43 $3,907 - $5,715	105 Added 6.89%	1,630 $74,000
Q4 2020 Feb 12, 2021	BUY	$30.19 - $45.49 $46,039 - $69,372	1,525 New	1,525 $60,000

266

161M

260K

620K

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.8B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.